The Incidental Economist - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
The FDA has introduced the Commissioner’s National Priority Voucher (CNPV) pilot, offering ultra‑fast approval pathways for drugs that align with the current White House policy agenda. The program could slash review times for qualifying products, giving participating companies a market advantage. However, the initiative raises concerns that political priorities may override scientific assessment, threatening the agency’s independence and public confidence. Stakeholders are debating whether speed should trump rigor in the regulatory process.
In 2021 CMS mandated hospitals to publish machine‑readable price lists for 300 common services, hoping transparent pricing would spur competition and lower costs. Five years later, health spending still outpaces inflation and the rule’s impact remains minimal. Low public awareness,...
